CPB2 Antikörper (HRP)
Kurzübersicht für CPB2 Antikörper (HRP) (ABIN7536745)
Target
Alle CPB2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- TAFI - Thrombin Activatable Fibrinolysis Inhibitor Polyclonal Antibody - HRP Conjugated
-
Spezifität
- Human thrombin-activatable fibrinolysis inhibitor, TAFI
-
Aufreinigung
- Fractionation of IgG from antiserum
-
Immunogen
- Human TAFI purified from plasma
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Immunoblot 5 μg/mL, ELISA detecting 10 μg/mL
-
Kommentare
-
Whole IgG is a base level product and refers to IgG antibodies purified from antiserum using multiple precipitation and dialysis steps. The purity of the IgG is typically 90% and is provided in a solution of HEPES buffered saline containing 50% glycerol (v/v). The titre is essentially the same as the starting antiserum and each vial typically contains the amount of IgG recovered from one millilitre of antiserum. This level of product is generally intended for use in applications such as immunoprecipitation, immunoelectrophoresis, immuno-depletion and activity neutralization assays.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Rekonstitution
- Allow product to warm to room temperature and gently mix before use
-
Konzentration
- 2 mg/mL
-
Buffer
- A buffered stabilizer solution containing 50 % (v/v) glycerol
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store between -10°C and -20°C
-
-
- CPB2 (Carboxypeptidase B2 (Plasma) (CPB2))
-
Andere Bezeichnung
- TAFI
-
Pathways
- Regulation of Actin Filament Polymerization, Carbohydrate Homeostasis
Target
-